![Gerhard Koenig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gerhard Koenig
Amministratore Delegato presso
Augustine Therapeutics NV
Profilo
Gerhard Koenig was the founder of Arkuda Therapeutics, Inc., founded in 2022, serving as President, Chief Executive Officer & Director.
Current jobs include Chief Executive Officer & Director at Augustine Therapeutics NV since 2022 and Advisor at Atlas Venture Advisors, Inc. since 2022.
Former jobs include Chief Executive Officer at Quartet Medicine, Inc. from 2016 to 2017; Independent Director at Vigil Neuroscience, Inc. from 2020 to 2025; Chief Scientific Officer & Senior Vice President at FORUM Pharmaceuticals, Inc. from 2003 to 2016; Vice President-Scientific Programs & Evaluation at F-Prime, Inc. from 2002 to 2004; and Scientific Board Advisor at Disarm Therapeutics, Inc. from 2017 to 2020.
Education includes graduate degree in 1988 and doctorate in 1991 from Ruprecht-Karls-Universität Heidelberg.
Posizioni attive di Gerhard Koenig
| Società | Posizione | Inizio |
|---|---|---|
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consulente / Consigliere | 01/01/2022 |
Augustine Therapeutics NV
 Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Provides therapies for tooth and neuromuscular diseases | Amministratore Delegato | 13/02/2025 |
Precedenti posizioni note di Gerhard Koenig
| Società | Posizione | Fine |
|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Direttore/Membro del Consiglio | 05/08/2025 |
Arkuda Therapeutics, Inc.
 Arkuda Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing medicines to improve the lives of patients with neurological diseases | Fondatore | 01/01/2024 |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat patients with neurological diseases | Consulente / Consigliere | 31/12/2020 |
Quartet Medicine, Inc.
 Quartet Medicine, Inc. BiotechnologyHealth Technology Develops treatments for chronic pain and inflammation | Amministratore Delegato | 31/10/2017 |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Investitore di Private Equity | 31/05/2016 |
Formazione di Gerhard Koenig
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
74
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America and South America. The firm targets companies operating in the fields of life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Finance |
Quartet Medicine, Inc.
Quartet Medicine, Inc. BiotechnologyHealth Technology Develops treatments for chronic pain and inflammation | Health Technology |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat patients with neurological diseases | Health Technology |
Arkuda Therapeutics, Inc.
Arkuda Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing medicines to improve the lives of patients with neurological diseases | Health Technology |
Augustine Therapeutics NV
Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Provides therapies for tooth and neuromuscular diseases | Health Services |
Vigil Neuroscience, Inc.
 Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
